Medication | No. (%) of patients | ||
---|---|---|---|
Previous diagnosis of asthma n = 181† | Previous diagnosis of COPD n = 34† | No previous diagnosis of asthma or COPD n = 127 | |
Short-acting β-agonist | 141 (77.9) | 22 (64.7) | 83 (65.4) |
Inhaled corticosteroid | 45 (24.9) | 3 (8.8) | 38 (29.9) |
Inhaled corticosteroid–long-acting β-agonist | 120 (66.3) | 30 (88.2) | 54 (42.5) |
Oral corticosteroid | 6 (3.3) | 2 (5.9) | 5 (3.9) |
Long-acting anticholinergic | 7 (3.9) | 13 (38.2) | 7 (5.5) |
Short-acting anticholinergic | 5 (2.8) | 2 (5.9) | 6 (4.7) |
Theophylline | 4 (2.2) | 1 (2.9) | 1 (0.8) |
Leukotriene antagonist | 20 (11.0) | 2 (5.9) | 5 (3.9) |